cliffwatch

corticotropin · Ani Pharms · NDA 008975

Purified Cortrophin Gel

Earliest generic entry, as listed
27 Oct 2043

Blocked by patent: US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 11975047, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12102662, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12233105, US 12324787, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12440542, US 12734217, US 12734217, US 12734217, US 12734217, US 12734217, US 12734217.

Listed patents · 99 unexpired

PatentClaimsExpires
US 11975047use U-392627 Oct 2043
US 11975047use U-392527 Oct 2043
US 11975047use U-392427 Oct 2043
US 11975047use U-392327 Oct 2043
US 11975047use U-392227 Oct 2043
US 11975047use U-392127 Oct 2043
US 11975047use U-392027 Oct 2043
US 11975047use U-391927 Oct 2043
US 11975047use U-391827 Oct 2043
US 11975047use U-391727 Oct 2043
US 11975047use U-391627 Oct 2043
US 11975047use U-391527 Oct 2043
US 11975047use U-390427 Oct 2043
US 11975047use U-391427 Oct 2043
US 11975047use U-391327 Oct 2043
US 11975047use U-391227 Oct 2043
US 11975047use U-391127 Oct 2043
US 11975047use U-391027 Oct 2043
US 11975047use U-390927 Oct 2043
US 11975047use U-390827 Oct 2043
US 11975047use U-390727 Oct 2043
US 11975047use U-390627 Oct 2043
US 11975047use U-390527 Oct 2043
US 12102662use U-392127 Oct 2043
US 12102662use U-392227 Oct 2043
US 12102662use U-392327 Oct 2043
US 12102662use U-392427 Oct 2043
US 12102662use U-392527 Oct 2043
US 12102662use U-392627 Oct 2043
US 12102662use U-390427 Oct 2043
US 12102662use U-390527 Oct 2043
US 12102662use U-390627 Oct 2043
US 12102662use U-390727 Oct 2043
US 12102662use U-390827 Oct 2043
US 12102662use U-390927 Oct 2043
US 12102662use U-391027 Oct 2043
US 12102662use U-391127 Oct 2043
US 12102662use U-391227 Oct 2043
US 12102662use U-391327 Oct 2043
US 12102662use U-391427 Oct 2043
US 12102662use U-391527 Oct 2043
US 12102662use U-391627 Oct 2043
US 12102662use U-391727 Oct 2043
US 12102662use U-391827 Oct 2043
US 12102662use U-391927 Oct 2043
US 12102662use U-392027 Oct 2043
US 12233105use U-391127 Oct 2043
US 12233105use U-391227 Oct 2043
US 12233105use U-391327 Oct 2043
US 12233105use U-391427 Oct 2043
US 12233105use U-391527 Oct 2043
US 12233105use U-391627 Oct 2043
US 12233105use U-391727 Oct 2043
US 12233105use U-391827 Oct 2043
US 12233105use U-391927 Oct 2043
US 12233105use U-392027 Oct 2043
US 12233105use U-392127 Oct 2043
US 12233105use U-392227 Oct 2043
US 12233105use U-392327 Oct 2043
US 12233105use U-392427 Oct 2043
US 12233105use U-392527 Oct 2043
US 12233105use U-392627 Oct 2043
US 12233105use U-390427 Oct 2043
US 12233105use U-390527 Oct 2043
US 12233105use U-390627 Oct 2043
US 12233105use U-390727 Oct 2043
US 12233105use U-390827 Oct 2043
US 12233105use U-390927 Oct 2043
US 12233105use U-391027 Oct 2043
US 12324787product27 Oct 2043
US 12440542product, use U-392627 Oct 2043
US 12440542product, use U-392527 Oct 2043
US 12440542product, use U-392427 Oct 2043
US 12440542product, use U-392327 Oct 2043
US 12440542product, use U-392227 Oct 2043
US 12440542product, use U-392127 Oct 2043
US 12440542product, use U-392027 Oct 2043
US 12440542product, use U-391927 Oct 2043
US 12440542product, use U-391827 Oct 2043
US 12440542product, use U-391727 Oct 2043
US 12440542product, use U-391627 Oct 2043
US 12440542product, use U-391527 Oct 2043
US 12440542product, use U-391427 Oct 2043
US 12440542product, use U-391327 Oct 2043
US 12440542product, use U-391027 Oct 2043
US 12440542product, use U-390927 Oct 2043
US 12440542product, use U-390827 Oct 2043
US 12440542product, use U-390727 Oct 2043
US 12440542product, use U-390627 Oct 2043
US 12440542product, use U-390527 Oct 2043
US 12440542product, use U-390427 Oct 2043
US 12440542product, use U-391127 Oct 2043
US 12440542product, use U-391227 Oct 2043
US 12734217product, use U-390427 Oct 2043
US 12734217product, use U-390727 Oct 2043
US 12734217product, use U-392427 Oct 2043
US 12734217product, use U-391227 Oct 2043
US 12734217product, use U-390527 Oct 2043
US 12734217product, use U-391627 Oct 2043

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 2

NDA · productFormStrengthListed expiry
008975 · 001 · discontinuedinjectable, injection40 UNITS/ML27 Oct 2043
008975 · 002 · RLDinjectable, injection80 UNITS/ML27 Oct 2043